An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
Clinical trial NCT01703923 · COMPLETED
Trial details
- NCT number
- NCT01703923
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.